Trisomy 18 and 13 screening: Consequences for the Dutch Down syndrome screening programme

Prenatal Diagnosis

Volumn 30, Issue 3, 2010, Pages 287-289

  Koster, M P H ^a,b   Stoutenbeek, P ^b   Visser, G H A ^b   Schielen, P C J I ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Edwards syndrome; First trimester combined test; Foetal imaging; Foetal ultrasound; Maternal serum screening; National policy; Patau syndrome

Indexed keywords

ALGORITHM; ARTICLE; DOWN SYNDROME; FETUS HEART RATE; FETUS MORTALITY; FOLLOW UP; HUMAN; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY DISORDER; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; TRISOMY 13; TRISOMY 18;

ABNORMALITIES, MULTIPLE; ADULT; ALGORITHMS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; NETHERLANDS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RISK FACTORS; TRISOMY;

EID: 77349113984     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2467     Document Type: Article

References (10)

1. Boyd PA, Lindenbaum RH, Redman C. 1987. Pre-eclampsia and trisomy 13: a possible association. Lancet 2(8556): 425-427.
2. Cuckle H. 2001. Edwards' syndrome. DS News 8(1): 23.
3. Cuckle H. 2006. Trisomies 18 & 13. DS News 13(2): 15.
4. Cuckle HS, Arbuzova S. 2004. Multimarker maternal serum screening for chromosomal abnormalities. In Genetic Disorder and the Fetus: Diagnosis, Prevention, and Treatment, Milunski A (ed.) Johns Hopkins University Press: Baltimore; 795-835.
5. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH. 2008. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. Hum Reprod 23(9): 1968-1975.
6. Koster MP, Wortelboer EJ, Engels MA, et al. 2009. Quality of nuchal translucency measurements in the Netherlands: a quantitative analysis. Ultrasound Obstet Gynecol 34(2): 136-141.
7. Spencer K, Ong C, Skentou H, Liao AW, Nicolaides K. 2000. Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 20(5): 411-416.
8. Tul N, Spencer K, Noble P, Chan C, Nicolaides K. 1999. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation. Prenat Diagn 19(11): 1035-1042.
9. Wortelboer EJ, Linskens IH, Koster MP, et al. 2009. ADAM12s as a first-trimester screening marker of trisomy. Prenat Diagn 29(9): 866-869.
10. Zaragoza E, Akolekar R, Poon LC, Pepes S, Nicolaides KH. 2009. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies. Ultrasound Obstet Gynecol 33(4): 382-386.